» Articles » PMID: 34858477

Inferring Differential Networks by Integrating Gene Expression Data With Additional Knowledge

Overview
Journal Front Genet
Date 2021 Dec 3
PMID 34858477
Authors
Affiliations
Soon will be listed here.
Abstract

Evidences increasingly indicate the involvement of gene network rewiring in disease development and cell differentiation. With the accumulation of high-throughput gene expression data, it is now possible to infer the changes of gene networks between two different states or cell types via computational approaches. However, the distribution diversity of multi-platform gene expression data and the sparseness and high noise rate of single-cell RNA sequencing (scRNA-seq) data raise new challenges for existing differential network estimation methods. Furthermore, most existing methods are purely rely on gene expression data, and ignore the additional information provided by various existing biological knowledge. In this study, to address these challenges, we propose a general framework, named weighted joint sparse penalized D-trace model (WJSDM), to infer differential gene networks by integrating multi-platform gene expression data and multiple prior biological knowledge. Firstly, a non-paranormal graphical model is employed to tackle gene expression data with missing values. Then we propose a weighted group bridge penalty to integrate multi-platform gene expression data and various existing biological knowledge. Experiment results on synthetic data demonstrate the effectiveness of our method in inferring differential networks. We apply our method to the gene expression data of ovarian cancer and the scRNA-seq data of circulating tumor cells of prostate cancer, and infer the differential network associated with platinum resistance of ovarian cancer and anti-androgen resistance of prostate cancer. By analyzing the estimated differential networks, we find some important biological insights about the mechanisms underlying platinum resistance of ovarian cancer and anti-androgen resistance of prostate cancer.

References
1.
Futreal P, Coin L, Marshall M, Down T, Hubbard T, Wooster R . A census of human cancer genes. Nat Rev Cancer. 2004; 4(3):177-83. PMC: 2665285. DOI: 10.1038/nrc1299. View

2.
Wang Y, Chen W, Xiao P, Xie W, Luo Q, Bork P . GEAR: A database of Genomic Elements Associated with drug Resistance. Sci Rep. 2017; 7:44085. PMC: 5353689. DOI: 10.1038/srep44085. View

3.
Lin H, Lin C, Huo C, Jan Y, Tseng J, Jiang S . AKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf, and TSC1/TSC2. Oncotarget. 2015; 6(29):27097-112. PMC: 4694976. DOI: 10.18632/oncotarget.4553. View

4.
Grechkin M, Logsdon B, Gentles A, Lee S . Identifying Network Perturbation in Cancer. PLoS Comput Biol. 2016; 12(5):e1004888. PMC: 4856318. DOI: 10.1371/journal.pcbi.1004888. View

5.
Miyamoto D, Zheng Y, Wittner B, Lee R, Zhu H, Broderick K . RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science. 2015; 349(6254):1351-6. PMC: 4872391. DOI: 10.1126/science.aab0917. View